LON:BIOG

The Biotech Growth Trust Interim Earnings Results & Report

The Biotech Growth Trust logo
GBX 1,354 +16.00 (+1.20%)
As of 12:28 PM Eastern

The Biotech Growth Trust reported Interim earnings on November 20, 2025. The company reported EPS of -GBX 1.

Earnings Announcement Details

Quarter
Interim
Time
Before Market Opens

The Biotech Growth Trust EPS Results

Actual EPS
-GBX 1
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

The Biotech Growth Trust Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

The Biotech Growth Trust Interim Earnings FAQ

The Biotech Growth Trust (LON:BIOG) reported earnings of -GBX 1 per share for Interim. The report was announced on Thursday, November 20, 2025.

The Biotech Growth Trust Earnings Headlines

The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 October 2026
Your book is inside
Blane Markham and the Markham Trading Team are giving readers a limited window to download their options strategy guide, titled How To Turn $100 Options Into $1,000 Gains, before it moves behind a paywall. The guide walks through options trading concepts the team uses in its own research and education materials. Once the paywall goes up, free access ends for good.tc pixel
The Biotech Growth Trust PLC - Total Voting Rights
(BIOGW) Biotech Growth Trust Plc
See More The Biotech Growth Trust Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like The Biotech Growth Trust? Sign up for Earnings360's daily newsletter to receive timely earnings updates on The Biotech Growth Trust and other key companies, straight to your email.

About The Biotech Growth Trust

The Biotech Growth Trust (LON:BIOG) seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

View The Biotech Growth Trust Profile